Consistent with research showing caspase-3’s role in colorectal cancer survival and proliferation pathways, the increased caspase-3 in HT-29 cells is probably due to compensatory responses or non-canonical signalling rather than traditional apoptosis activation [77]. The gene discussed is CASP3; the disease is colorectal cancer.